Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,286,838 papers from all fields of science
Search
Sign In
Create Free Account
METTL8 gene
Known as:
TENSION-INDUCED/INHIBITED PROTEIN
, FLJ13984
, methyltransferase like 8
Expand
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
The SUMOylated METTL8 Induces R-loop and Tumorigenesis via m3C
Lihua Zhang
,
Xueyun Zhang
,
+6 authors
Xiang Gao
iScience
2020
Corpus ID: 214607310
2020
2020
Expression profile analyses of mettl8 in Oryzias latipes
W. Pang
,
Ziwei Zhao
,
Yawei Shen
,
Yan-hui Bi
,
Yifeng Gu
,
Xiaowu Chen
Fish Physiology & Biochemistry
2020
Corpus ID: 210926354
Methyltransferase-like 8 (mettl8) is a protein-coding gene that may demonstrate nucleic acid or protein methyltransferase…
Expand
Review
2019
Review
2019
The interactome of a family of potential methyltransferases in HeLa cells
V. Ignatova
,
P. Jansen
,
Marijke P. A. Baltissen
,
M. Vermeulen
,
R. Schneider
Scientific Reports
2019
Corpus ID: 139105949
Human methytransferase like proteins (METTL) are part of a large protein family characterized by the presence of binding domains…
Expand
2018
2018
Frameshift Mutations in Repeat Sequences of ANK3, HACD4, TCP10L, TP53BP1, MFN1, LCMT2, RNMT, TRMT6, METTL8 and METTL16 Genes in Colon Cancers
Su Yeon Yeon
,
Y. Jo
,
Eun Ji Choi
,
M. S. Kim
,
N. Yoo
,
S. Lee
Pathology and Oncology Research
2018
Corpus ID: 4053343
Diminished ANK3 contributes to cell survival by inhibiting detachment-induced apoptosis. TP53BP1 that interacts with p53 and MFN1…
Expand
2018
2018
The STAT3 Target Mettl8 Regulates Mouse ESC Differentiation via Inhibiting the JNK Pathway
Hao Gu
,
D. Do
,
+11 authors
Xin-Yuan Fu
Stem Cell Reports
2018
Corpus ID: 14027184
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE